Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified–warmed embryo transfer outcomes in women with adenomyosis
article
OA: closed
CC0
⤵ 18 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (44)
- Adenomyosis and female fertility: A critical review of the evidence via openalex
- Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes via openalex
- Adenomyosis and Subfertility: Evidence of Association and Causation via openalex
- Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment via openalex
- Adenomyosis reduces pregnancy rates in infertile women undergoing IVF via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging via openalex
- Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis via openalex
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium via openalex
- Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
- Infertility and Adenomyosis via openalex
- Insertion of the Mirena Intrauterine System for Treatment of Adenomyosis-Associated Menorrhagia: A Novel Method via openalex
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system via openalex
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview via openalex
- The Role of Hysteroscopy in the Diagnosis and Treatment of Adenomyosis via openalex
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy via openalex
- Uterine junctional zone at magnetic resonance imaging: A predictor of <i>in vitro</i> fertilization implantation failure via openalex
- W2082484095 via openalex
- W2040770590 via openalex
- W2088267656 via openalex
- W2105587557 via openalex
- W2038354928 via openalex
- W2118661243 via openalex
- W2133909395 via openalex
- W2135935849 via openalex
- W2037163508 via openalex
- W2034864360 via openalex
- W2030538772 via openalex
- W2008601163 via openalex
- W1989426617 via openalex
- W2177604550 via openalex
- W2314028403 via openalex
- W1933506009 via openalex
- W2404035724 via openalex
- W2410411656 via openalex
- W2526537533 via openalex
- W2532361426 via openalex
- W2606543363 via openalex
- W1787787700 via openalex
- W2788509085 via openalex
- W2796984652 via openalex
- W4285719527 via openalex
Cited by (18)
- CNC–PNIPAM Drug Delivery System Improves Endometrial Receptivity via Natural Killer Cell Immune Tolerance in Endometriosis 2026
- The biology and clinical aspects of female infertility 2026
- The biology and clinical aspects of female infertility 2026
- Fertility outcome following ovarian stimulation in infertile women having pretreatment with levonorgestrel releasing intrauterine system versus dienogest for symptomatic adenomyosis 2025
- Strategies to Improve Assisted Reproductive Technique Outcomes in Women with Adenomyosis: A Narrative Review 2025
- Consider fertility-preserving medications when treating adenomyosis 2024
- Guideline No. 437: Diagnosis and Management of Adenomyosis 2023
- The role of the junctional zone in the management of adenomyosis with infertility 2023
- Presence of Adenomyosis Impairs Clinical Outcomes in Women Undergoing Frozen Embryo Transfer: A Retrospective Cohort Study 2023
- Directive clinique no 437 : Diagnostic et prise en charge de l’adénomyose 2023
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights 2022
- Impact of Adenomyosis on Infertile Patients—Therapy Options and Reproductive Outcomes 2022
- Medical Treatment of Adenomyosis 2022
- Adenomyosis and Reproduction: a Narrative Review 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis 2022
- The impact of adenomyosis on IVF outcomes: a prospective cohort study 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:48.502547+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK